Common Contracts
6 similar Sales Agreement contracts by Nautilus Biotechnology, Inc., Acrivon Therapeutics, Inc., Alector, Inc., others
MORPHIC HOLDING, INC. SALES AGREEMENTSales Agreement • April 26th, 2024 • Morphic Holding, Inc. • Pharmaceutical preparations • New York
VTV THERAPEUTICS INC. CLASS A COMMON STOCK SALES AGREEMENTSales Agreement • February 28th, 2024 • vTv Therapeutics Inc. • Pharmaceutical preparations • New York
NAUTILUS BIOTECHNOLOGY, INC. SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE SALES AGREEMENTSales Agreement • February 28th, 2024 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments • New York
Nautilus Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
NAUTILUS BIOTECHNOLOGY, INC. SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE SALES AGREEMENTSales Agreement • February 28th, 2024 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments • New York
Nautilus Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
ACRIVON THERAPEUTICS, INC. SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE SALES AGREEMENTSales Agreement • December 1st, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • New York
Acrivon Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
ALECTOR, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 7th, 2023 • Alector, Inc. • Biological products, (no disgnostic substances) • New York
